Improved breast cancer prognosis through the combination of clinical and genetic markers.

ABSTRACT:

Motivation

Accurate prognosis of breast cancer can spare a significant number of breast cancer patients from receiving unnecessary adjuvant systemic treatment and its related expensive medical costs. Recent studies have demonstrated the potential value of gene expression signatures in assessing the risk of post-surgical disease recurrence. However, these studies all attempt to develop genetic marker-based prognostic systems to replace the existing clinical criteria, while ignoring the rich information contained in established clinical markers. Given the complexity of breast cancer prognosis, a more practical strategy would be to utilize both clinical and genetic marker information that may be complementary.

Methods

A computational study is performed on publicly available mic

SUBMITTER: Sun Y 

PROVIDER: S-EPMC3431620 | biostudies-literature | 2007 Jan

REPOSITORIES: biostudies-literature